Vast Therapeutics (formerly Novoclem) Announces Results.
May 22, 2018
DURHAM, N.C., May 22, 2018 /PRNewswire/ — Vast Therapeutics, Inc., formerly Novoclem Therapeutics, Inc. (the Company), a preclinical stage pharmaceutical company focused on delivering the power of nitric oxide (NO) in a synthetically derived powder-based form, announced today that the Company’s first controlled NO-release powder based ..
Anne Whitaker keynote speaker for Novoclem Therapeutics, Inc.
Feb 27-28, 2018
The Council for Entrepreneurial Development hosted the 27th annual CED Life Science Conference on February 27-28, 2018 in Raleigh, NC. As the premier life science event in the Southeast, the conference attracted nearly 1,000 attendees including trailblazing entrepreneurs, investors, corporate leaders, and industry visionaries from across the nation.
Novoclem announces CEO Anne Whitaker to present at the BIO CEO
Feb 8, 2018
DURHAM, NC ( Feb. 8, 2018) – Novoclem Therapeutics, a preclinical-stage pharmaceutical company focused on helping people who suffer from severe respiratory diseases to breathe better and live life more fully, today announced that it will present at the Bio CEO & Investor Conference, to be held February 12th –13th at the New York Marriott Marquis.
Sign up for Email Alerts
Please fill out the form below to receive company press releases via email when they occur.